Apple Analyst Sees $900 Ahead and 4 Stock Insights Make Rounds Tuesday

Boeing Co. (NYSE:BA) delivery growth is expected by Bernstein to continue, based on the company’s current high backlogs, and it will provide a catalyst for the stock. The firm adds that the company will see benefits from ramping up production of its 787, and it keeps its Outperform rating

Calpine Corp. (NYSE:CPN) estimates have been reduced by SunTrust to below consensus for 2013 and 2014. This decision is based on lowered power output assumptions in order to reflect the reversal to gas from coal as a result of higher forward prices and lower spark spreads. Shares have a Neutral rating.

Are these stocks a buy or sell? Let us help you decide. Check out our Wall St. Cheat Sheet Stock Picker Newsletter now >>

Apple Inc. (NASDAQ:AAPL) is expected by Jefferies to report in-line Q3 results, but the firm thinks that the company’s typically conservative guidance will be more in-line with the Q4 consensus than they had ever considered. The shares have a Buy rating and a $900 price target.

E2open, Inc. (NASDAQ:EOPN) price target has been increased by Bank of America Merrill Lynch because of its sustainable +25 percent growth and pricing leverage. Shares have a Buy rating.

Gilead Sciences Inc. (NASDAQ:GILD): According to RBC Capital, data released by Gilead competitors Abbott (NYSE:ABT) and Bristol-Myers (NYSE:BMY) will not affect Gilead’s outlook, since the firm believes that Bristol-Myers continues to have the best opportunity in HCV. The firm believes that Gilead will report good combo data at AASLD, which will push the stock higher. It keeps its Outperform rating on the stock.

Don’t Miss: Are Procter & Gamble Shares a Buy Now?